| Hans-Günter Meyer-Thompson | Überdosis - Drogentod
USA. FDA Grants Purdue Pharma’s Nalmefene HCl Injection Fast Track Designation for the Emergency Treatment of Known or Suspected Opioid Overdose
USA. FDA Grants Purdue Pharma’s Nalmefene HCl Injection Fast Track Designation for the
Emergency Treatment of Known or Suspected Opioid Overdose
Committed to advancing solutions to the opioid public health crisis, Purdue will not profit from nalmefene HCl. (Purdue Pharma L.P, USA, 13.03.2019)